Nanostructured Materials for Biological and Pharmaceutical Applications (Third Edition)
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 27 February 2026 | Viewed by 772
Special Issue Editor
Interests: functional liposomes; functional dendritic polymers; carbon-based nanostructured materials; nano-sized drug delivery systems; drug targeting; triggered drug release; antibacterial agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology is an emerging field that involves the manipulation of matter at the nanometer scale, resulting in a new class of materials with enhanced properties for a wide range of applications. In terms of terminology, nanotechnology is defined as the science and engineering concerned with the design, synthesis, characterization, and application of materials and devices with at least one dimension at the nanometer scale. Currently, nanomedicine—which focuses on the diagnosis, prevention, and treatment of various diseases using nanoscale tools—and biomedical engineering are among the most promising and challenging fields in the application of nanostructured materials. Nanostructured materials—including inorganic or organic, crystalline or amorphous forms, and supramolecular structures such as micelles, liposomes, polymersomes, dendrimers, cyclodextrins, polymeric, metal and metal oxide nanoparticles, lipid and polymeric nanocapsules, carbon nanostructures, quantum dots, and others—have been widely used in biological and pharmaceutical applications due to their excellent structural properties and their ability to be functionalized with specific ligands. These features allow for controllable size and shape, enhanced targetability, high loading capacity, and controlled release of drugs and other bioactive molecules. Although various types of nanostructured materials have been developed and proposed for biological applications, only a limited number have received approval, primarily due to challenges related to biocompatibility, pharmacokinetics, and in vivo targeting efficacy. Therefore, there is still significant room for improvement, particularly in addressing issues such as cytotoxicity, immunogenicity, and limited biocompatibility more extensively.
The aim of this Special Issue is to highlight recent advances in all aspects relevant to the design, synthesis, and characterization of nanostructured materials, for intended applications such as drug and gene delivery systems, stimulus-responsive therapeutics, bioimaging agents, bioanalytical diagnostics, theranostics, tissue engineering scaffolds and devices, and antibacterial agents, among possible others. This Special Issue of Nanomaterials will collate original high-quality research papers focused on the most recent advances and comprehensive reviews addressing state-of-the-art topics in the field of various nanostructured materials for biological and pharmaceutical applications.
Dr. Zili Sideratou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanostructured materials
- drug and gene delivery systems
- stimuli-responsive therapeutics
- bioimaging agents
- bio-analytical diagnostics
- theranostics
- antibacterial/antimicrobial/antiviral agents
- drug targeting
- triggered drug release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
